Regional depth Target pharmaceutical companies seeking entry or expansion in Latin America and the Caribbean, emphasizing IRIS Global’s regional regulatory expertise and local market understanding as a differentiator from larger global firms.

Regulatory risk Prospect for firms experiencing incomplete or poor regulatory filings, offering services to restore market access, ensure ongoing compliance, and reduce rework and delays driven by evolving Latin American regulations.

Full-service partner Position as an on-demand regulatory affairs team for a country or the entire region, highlighting end-to-end capabilities from dossier preparation and in-country filings to responding to health authorities and tracking approval milestones.

Cost-competitive niche Leverage a lean 2-10 employee profile and strategic U.S. presence to offer affordable, scalable regulatory support that competes with larger firms, appealing to mid-market and regional players with modest budgets.

Digital presence edge Highlight tech-enabled engagement through a modern tech stack and analytics familiarity to support data-driven regulatory strategies and performance tracking for submissions and market access timelines.